These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 9268085

  • 1. Neuroprotective effect of YM90K, an AMPA-receptor antagonist, against delayed neuronal death induced by transient global cerebral ischemia in gerbils and rats.
    Kawasaki-Yatsugi S, Yatsugi S, Koshiya K, Shimizu-Sasamata M.
    Jpn J Pharmacol; 1997 Jul; 74(3):253-60. PubMed ID: 9268085
    [Abstract] [Full Text] [Related]

  • 2. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
    Shimizu-Sasamata M, Kawasaki-Yatsugi S, Okada M, Sakamoto S, Yatsugi S, Togami J, Hatanaka K, Ohmori J, Koshiya K, Usuda S, Murase K.
    J Pharmacol Exp Ther; 1996 Jan; 276(1):84-92. PubMed ID: 8558460
    [Abstract] [Full Text] [Related]

  • 3. Effects of the AMPA-receptor antagonist, NBQX, on neuron loss in dentate hilus of the hippocampal formation after 8, 10, or 12 min of cerebral ischemia in the rat.
    Hu P, Diemer NH, Bruhn T, Johansen FF.
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):147-52. PubMed ID: 9040493
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological evidence for a correlation between hippocampal CA1 cell damage and hyperlocomotion following global cerebral ischemia in gerbils.
    Katsuta K, Umemura K, Ueyama N, Matsuoka N.
    Eur J Pharmacol; 2003 Apr 25; 467(1-3):103-9. PubMed ID: 12706462
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The neuroprotective and hypothermic effect of GYKI-52466, a non-competitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-antagonist on histological and behavioural variables in the gerbil global ischemia model.
    Gyertyán I, Gigler G, Simó A.
    Brain Res Bull; 1999 Oct 25; 50(3):179-86. PubMed ID: 10566979
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Neuroprotective effects of the AMPA antagonist PNQX in oxygen-glucose deprivation in mouse hippocampal slice cultures and global cerebral ischemia in gerbils.
    Montero M, Nielsen M, Rønn LC, Møller A, Noraberg J, Zimmer J.
    Brain Res; 2007 Oct 26; 1177():124-35. PubMed ID: 17894933
    [Abstract] [Full Text] [Related]

  • 10. A potent AMPA/kainate receptor antagonist, YM90K, attenuates the loss of N-acetylaspartate in the hippocampal CA1 area after transient unilateral forebrain ischemia in gerbils.
    Nakano M, Ueda H, Li JY, Matsumoto M, Yanagihara T.
    Life Sci; 2001 Sep 14; 69(17):1983-90. PubMed ID: 11589513
    [Abstract] [Full Text] [Related]

  • 11. Protection against post-ischaemic neuronal loss in gerbil hippocampal CA1 by glycineB and AMPA antagonists. Short communication.
    Lazarewicz JW, Gadamski R, Parsons CG, Danysz W.
    J Neural Transm (Vienna); 1997 Sep 14; 104(11-12):1249-54. PubMed ID: 9503269
    [Abstract] [Full Text] [Related]

  • 12. YM872: a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist.
    Takahashi M, Kohara A, Shishikura J, Kawasaki-Yatsugi S, Ni JW, Yatsugi S, Sakamoto S, Okada M, Shimizu-Sasamata M, Yamaguchi T.
    CNS Drug Rev; 2002 Sep 14; 8(4):337-52. PubMed ID: 12481190
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. YM90K, an AMPA receptor antagonist, protects against ischemic damage caused by permanent and transient middle cerebral artery occlusion in rats.
    Kawasaki-Yatsugi S, Ichiki C, Yatsugi S, Shimizu-Sasamata M, Yamaguchi T.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov 14; 358(5):586-91. PubMed ID: 9840429
    [Abstract] [Full Text] [Related]

  • 15. The AMPA-receptor antagonist YM90K reduces AMPA receptor-mediated excitotoxicity in rat hippocampal cultures.
    Ohno K, Okada M, Tsutsumi R, Sakamoto S, Yamaguchi T.
    Jpn J Pharmacol; 1998 Jan 14; 76(1):105-8. PubMed ID: 9517411
    [Abstract] [Full Text] [Related]

  • 16. Neuroprotective properties of the novel antiepileptic lamotrigine in a gerbil model of global cerebral ischemia.
    Wiard RP, Dickerson MC, Beek O, Norton R, Cooper BR.
    Stroke; 1995 Mar 14; 26(3):466-72. PubMed ID: 7886726
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Neuroprotective interaction effects of NMDA and AMPA receptor antagonists in an in vitro model of cerebral ischemia.
    Arias RL, Tasse JR, Bowlby MR.
    Brain Res; 1999 Jan 23; 816(2):299-308. PubMed ID: 9878799
    [Abstract] [Full Text] [Related]

  • 20. AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h.
    Sheardown MJ, Suzdak PD, Nordholm L.
    Eur J Pharmacol; 1993 Jun 04; 236(3):347-53. PubMed ID: 7689464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.